Tirzepatide is a medication that interacts with two hormone receptors involved in metabolic signaling: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Both hormones play a role in appetite regulation and glucose metabolism. By engaging multiple pathways, Tirzepatide influences how the body responds to food intake and energy use.